Kick the brand name habit

With everything, everywhere seemingly “breaking bad,” let’s look at an economic-educational-health bright spot: Generic drugs. A new study shows that in 2012, the use of generic medications jumped 8 percent; while the use of name-brand prescription medications dropped by 20.7 percent in the same period, USA Today reported.

The change likely reflects that several medications came off patent and were therefore available as generic medications, and it may also be a product of people on high-deductible insurance plans choosing cheaper medications, according to the Health Care Cost Institute, a non-profit group that conducted the research. The steep drop in name-brand drug use led to an overall decrease in spending on those drugs despite a 25.4 percent increase in prescription drug prices.

Using generics, and other smart moves, are not new to health care in the Northwest, and the researchers note the difference: Spending overall is highest in the Northeast and lowest in the West, while out-of-pocket spending is highest in the South and lowest in the West.

Still, some people won’t veer from their name-brand prescription or over-the-counter medication, even though their generic versions work equally well. Which illustrates the power of advertising. A study by the University of Chicago Business School about “branding effects” found that high-income households are much more likely to buy name-brand headache remedies than low-income households, Slate reported in June. This finding holds true except for doctors, nurses and pharmacists, because they know better. (Professional pharmacists, the most informed people on the subject, are the least likely of them all to buy the expensive name-brand drugs.)

In total, the study found, Americans waste about $32 billion a year in buying name-brand pills over the counter where generic alternatives are readily available. Importantly, a willingness to buy generic drugs is strongly correlated with the ability to correctly identify the active ingredient in name-brand pills, researchers said. That’s where doctors, nurses, pharmacists and insurance companies need to start, or continue, their educational efforts about generic medicine, and what to look for. (Most generics helpfully put “Compare to the ingredients in Tylenol” on their labels, for example, to make it easier for people, because the scientific names for ingredients do get confusing in a hurry.) A personal testimonial to a patient from a doctor, nurse or pharmacist that they themselves use generics is another simple but extremely powerful tool.

For good and for bad, Americans are seen as “consumers” when it comes to health care. Choice is always good, except when it’s misleading, and costly. Commercials and pharmaceutical companies are very persuasive. But they’re not the only ones motivated by money. (And own well-being.) Be smart, choose generic.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Tuesday, March 19

A sketchy look at the news of the day.… Continue reading

Students use a 3D model to demonstrate their groups traffic solutions at Hazelwood Elementary School on Wednesday, March 29, 2023 in Lynnwood, Washington. (Olivia Vanni / The Herald)
Editorial: Your choice, drivers; slow down or pay up

More traffic cameras will soon be in use in cities and highways, with steep penalties for violations.

Protect Affordable Care Act by rejecting Trump

The stakes are high in this year’s presidential election. If candidate Donald… Continue reading

Support candidates who support schools

I promised I would stop writing these letters because the gates of… Continue reading

Biden must stop supplying weapons to Israel, Ukraine

Bad foreign policy will come back to haunt us in the long… Continue reading

Comment: Flow of U.S. guns into Mexico is other border crisis

Guns, legal and illegal, are contributing to crime and instability in Mexico, driving many to seek asylum.

RGB version
Editorial cartoons for Monday, March 18

A sketchy look at the news of the day.… Continue reading

Carson gets a chance to sound the horn in an Everett Fire Department engine with the help of captain Jason Brock during a surprise Make-A-Wish sendoff Saturday, Oct. 21, 2023, at Thornton A. Sullivan Park in Everett, Washington. (Ryan Berry / The Herald)
Editorial: Everett voters will set course for city finances

This fall and in coming years, they will be asked how to fund and support the services they use.

Devotees of TikTok, Mona Swain, center, and her sister, Rachel Swain, right, both of Atlanta, monitor voting at the Capitol in Washington, as the House passed a bill that would lead to a nationwide ban of the popular video app if its China-based owner doesn't sell, Wednesday, March 13, 2024. Lawmakers contend the app's owner, ByteDance, is beholden to the Chinese government, which could demand access to the data of TikTok's consumers in the U.S. (AP Photo/J. Scott Applewhite)
Editorial: Forced sale of TikTok ignores network of problems

The removal of a Chinese company would still leave concerns for data privacy and the content on apps.

Rep. Strom Peterson, D-Edmonds, watches the State of the State speech by Gov. Jay Inslee on the second day of the legislative session at the Washington state Capitol, Tuesday, Jan. 9, 2024, in Olympia, Wash. (AP Photo/Lindsey Wasson)
Editorial: Legislature has its own production of ‘The Holdovers’

What state lawmakers left behind in good ideas that should get more attention and passage next year.

Comment: Measles outbreaks show importance of MMR vaccinations

The highly contagious disease requires a 95 percent vaccination rate to limit the spread of outbreaks.

Harrop: Should ‘affordable’ come at cost of quality of living?

As states push their cities to ignore zoning rules, the YIMBYs are covering for developers.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.